References
- Leopardi D, Hoggan BL, Fitridge RA, Woodruff PW, Maddern GJ. A systematic review of treatments for varicose veins. Ann Vasc Surg. 2009;23(2):264–76. doi:https://doi.org/10.1016/j.avsg.2008.10.007.
- Gwozdzinski L, Pieniazek A, Bernasinska J, Grabowski M, Kowalczyk E, Gwozdzinski K. Erythrocytes properties in varicose veins patients. Microvasc Res. 2017;111:72–9. doi:https://doi.org/10.1016/j.mvr.2016.12.005.
- Lichota A, Gwozdzinski L, Gwozdzinski K. Therapeutic potential of natural compounds in inflammation and chronic venous insufficiency. Eur J Med Chem. 2019;176:68–91. doi:https://doi.org/10.1016/j.ejmech.2019.04.075.
- Onida S, Lane TR, Davies AH. Varicose veins and their management. Surgery (Oxford). 2013;31(5):211–7. doi:https://doi.org/10.1016/j.mpsur.2013.02.002.
- Wang M, Sharma AK. Varicose veins. J Radiol Nurs. 2019;38(3):150–4. doi:https://doi.org/10.1016/j.jradnu.2019.04.004.
- Joseph N, B A, Faizan Thouseef M, Devi M U, Abna A, Juneja I. A multicenter review of epidemiology and management of varicose veins for national guidance. Ann Med Surg. 2016;8:21–7. doi:https://doi.org/10.1016/j.amsu.2016.04.024.
- Bootun R, Onida S, Lane TR, Davies AH. Varicose veins and their management. Surgery (Oxford). 2016;34(4):165–71. doi:https://doi.org/10.1016/j.mpsur.2016.02.002.
- Shrestha P, Karmacharya RM, Dahal S, Dhakal P, Bhandari N, Bade S. Patient literacy on varicose veins in cases presenting at the university hospital of Nepal subjected for surgical management of varicose veins. J Vasc Nurs. 2021;39(1):2–5. doi:https://doi.org/10.1016/j.jvn.2021.01.002.
- Poredos P, Spirkoska A, Rucigaj T, Fareed J, Jezovnik MK. Do blood constituents in varicose veins differ from the systemic blood constituents? Eur J Vasc Endovasc Surg. 2015;50(2):250–6. doi:https://doi.org/10.1016/j.ejvs.2015.04.031.
- Beaglehole R. Epidemiology of varicose veins. World J Surg. 1986;10(6):898–902. doi:https://doi.org/10.1007/BF01658637.
- Gibson K, Gunderson K. Liquid and foam sclerotherapy for spider and varicose veins. Surg Clin North Am. 2018;98(2):415–29. doi:https://doi.org/10.1016/j.suc.2017.11.010.
- Mashour NH, Lin GI, Frishman WH. Herbal medicine for the treatment of cardiovascular disease: clinical considerations. Arch Intern Med. 1998;158(20):2225–34. doi:https://doi.org/10.1001/archinte.158.20.2225.
- Ramanunny AK, Wadhwa S, Gulati M, Singh SK, Kapoor B, Dureja H, Chellappan DK, et al. Nanocarriers for treatment of dermatological diseases: Principle, perspective, and practices. Eur J Pharmacol. 2020;89:173691
- Darvall KAL, Bate GR, Adam DJ, Bradbury AW. Generic health-related quality of life is significantly worse in varicose vein patients with lower limb symptoms independent of CEAP clinical grade. Eur J Vasc Endovasc Surg. 2012;44(3):341–4. doi:https://doi.org/10.1016/j.ejvs.2012.06.022.
- Tan MK, Sutanto SA, Onida S, Davies AH. The relationship between vein diameters, clinical severity, and quality of life: a systematic review. Eur J Vasc Endovasc Surg. 2019;57(6):851–857. doi:https://doi.org/10.1016/j.ejvs.2019.01.024.
- Atta HM. Varicose veins: role of mechanotransduction of venous hypertension. Int J Vasc Med. 2012;2012:538627. doi:https://doi.org/10.1155/2012/538627.
- Mansilha A, Sousa J. Pathophysiological mechanisms of chronic venous disease and implications for vanoactive drug therapy. IJMS. 2018;19(6):1669. doi:https://doi.org/10.3390/ijms19061669.
- Ismail L, Normahani P, Standfield NJ, Jaffer U. A systematic review and meta-analysis of the risk for development of varicose veins in women with a history of pregnancy. J Vasc Surg Venous Lymphat Disord. 2016;4(4):518–24. doi:https://doi.org/10.1016/j.jvsv.2016.06.003.
- Raffetto JD, Khalil RA. Matrix metalloproteinases in venous tissue remodeling and varicose vein formation. Curr Vasc Pharmacol. 2008;6(3):158–72. doi:https://doi.org/10.2174/157016108784911957.
- Raffetto JD, Khalil RA. Mechanisms of varicose vein formation: valve dysfunction and wall dilation. Phlebology. 2008;23(2):85–98. doi:https://doi.org/10.1258/phleb.2007.007027.
- Ghaderian SMH, Lindsey NJ, Graham AM, Homer-Vanniasinkam S, Akbarzadeh Najar R. Pathogenic mechanisms in varicose vein disease: the role of hypoxia and inflammation. Pathology. 2010;42(5):446–53. doi:https://doi.org/10.3109/00313025.2010.493865.
- Ratych RE, Chuknyiska RS, Bulkley GB. The primary localization of free radical generation after anoxia/reoxygenation in isolated endothelial cells. Surgery. 1987;102(2):122–31.
- Ciuffetti G, Mannarino E, Paltriccia R, Malagigi V, Sergi F, Paulisch P, Pasqualini L, Lupattelli G. Leucocyte activity in chronic venous insufficiency. Int. Angiol. 1994;13:312–6.
- Perrin M, Ramelet AA. Pharmacological treatment of primary chronic venous disease: rationale, results and unanswered questions. Eur J Vasc Endovasc Surg. 2011;41(1):117–25. doi:https://doi.org/10.1016/j.ejvs.2010.09.025.
- Shadrina A, Tsepilov Y, Sokolova E, Smetanina M, Voronina E, Pakhomov E, et al. A genome-wide association study in ethnic Russians suggests an association of the MHC class III genomic region with the risk of primary varicose veins. Gene. 2018;659:93–9. doi:https://doi.org/10.1016/j.gene.2018.03.039.
- Raju S, Neglen P. Clinical practice. Chronic venous insufficiency and varicose veins. N Engl J Med. 2009;360(22):2319–27. doi:https://doi.org/10.1056/NEJMcp0802444.
- Tafur AJ, Rathbun S. 2013. Varicose veins. In Vascular medicine: A companion to Braunwald's heart disease. (pp. 639–51). WB Saunders.
- Kistner RL, Eklof B, Masuda EM. Diagnosis of chronic venous disease of the lower extremities: the “CEAP” classification. Mayo Clin Proc. 1996;71(4):338–45. doi:https://doi.org/10.4065/71.4.338.
- Van Rij AM, De Alwis CS, Jiang P, Christie RA, Hill GB, Dutton SJ, Thomson IA. Obesity and impaired venous function. Eur J Vasc Endovas Surg. 2008;35(6):739–44. doi:https://doi.org/10.1016/j.ejvs.2008.01.006.
- Davies HO, Popplewell M, Singhal R, Smith N, Bradbury AW. Obesity and lower limb venous disease – the epidemic of phlebesity. Phlebology. 2017;32(4):227–33. doi:https://doi.org/10.1177/0268355516649333.
- Iannuzzi A, Panico S, Ciardullo AV, Bellati C, Cioffi V, Iannuzzo G, Celentano E, Berrino F, Rubba P. Varicose veins of the lower limbs and venous capacitance in postmenopausal women: relationship with obesity. J Vasc Surg. 2002;36(5):965–8. doi:https://doi.org/10.1067/mva.2002.128315.
- Danielsson G, Eklof B, Grandinetti A, & L, Kistner R. The influence of obesity on chronic venous disease. Vasc Endovascular Surg. 2002;36(4):271–6. doi:https://doi.org/10.1177/153857440203600404.
- Devi MAS, Aathi MMK. Prevention of varicose veins. Int J Adv Nurs Manage. 2014;2(1):40–5.
- Moorthy RS. Doppler ultrasound. Med J Armed Force India. 2002;58(1):1–2. doi:https://doi.org/10.1016/S0377-1237(02)80001-6.
- Azarbeh N. 2020. Varicose veins: Causes, treatment, diagnosis, and prevention.
- De Maeseneer M, Pichot O, Cavezzi A, Earnshaw J, van Rij A, Lurie F, Smith PC. Duplex ultrasound investigation of the veins of the lower limbs after treatment for varicose veins – UIP consensus document. Eur J Vasc Endovasc Surg. 2011;42(1):89–102. doi:https://doi.org/10.1016/j.ejvs.2011.03.013.
- Coleridge-Smith P, Labropoulos N, Partsch H, Myers K, Nicolaides A, Cavezzi A. Duplex ultrasound investigation of the veins in the chronic venous disease of the lower limbs—UIP Consensus Document. Part I: Basic principles. Phlebology. 2006;21(4):158–67. doi:https://doi.org/10.1258/026835506779115780.
- Diaz JA. Basic-science leading the way for prevention and treatment of varicose veins. J Vasc Surg Venous Lymphat Disord. 2021;9(1):252–3. doi:https://doi.org/10.1016/j.jvsv.2020.04.020.
- Conway RG, Almeida JI, Kabnick L, Wakefield TW, Buchwald AG, Lal BK. Clinical response to combination therapy in the treatment of varicose veins. J Vasc Surg Venous Lymphat Disord. 2020;8(2):216–23.
- Jia X, Mowatt G, Burr JM, Cassar K, Cook J, Fraser C. A systematic review of foam sclerotherapy for varicose veins. Br J Surg. 2007;94(8):925–36. doi:https://doi.org/10.1002/bjs.5891.
- Kakkos SK, Bountouroglou DG, Azzam M, Kalodiki E, Daskalopoulos M, Geroulakos G. Effectiveness and safety of ultrasound-guided foam sclerotherapy for recurrent varicose veins: immediate results. J Endovasc Ther. 2006;13(3):357–64. doi:https://doi.org/10.1583/05-1781.1.
- Haruta N. Recent progress of varicose vein treatment especially about endovascular heat ablation, SEPS and foam sclerotherapy. Ann Vasc Dis. 2018;11(1):66–71. doi:https://doi.org/10.3400/avd.ra.18-00005.
- Albanese G, Kondo KL. Pharmacology of sclerotherapy. Semin Intervent Radiol. 2010;27(4):391–9. doi:https://doi.org/10.1055/s-0030-1267848.
- Eckmann DM. Polidocanol for endovenous microfoam sclerosant therapy. Expert Opin Investig Drugs. 2009;18(12):1919–27. doi:https://doi.org/10.1517/13543780903376163.
- Takeuchi Y, Morishita H, Sato Y, Hamaguchi S, Sakamoto N, Tokue H, Yonemitsu T, Murakami K, Fujiwara H, Sofue K, et al. Guidelines for the use of NBCA in vascular embolization devised by the Committee of Practice Guidelines of the Japanese Society of Interventional Radiology (CGJSIR), 2012 edition. Jpn J Radiol. 2014;32(8):500–17. doi:https://doi.org/10.1007/s11604-014-0328-7.
- Forlee MV, Grouden M, Moore DJ, Shanik G. Stroke after varicose vein foam injection sclerotherapy. J Vasc Surg. 2006;43(1):162–4. doi:https://doi.org/10.1016/j.jvs.2005.09.032.
- Sadick NS. Advances in the treatment of varicose veins: ambulatory phlebectomy, foam sclerotherapy, endovascular laser, and radiofrequency closure. Dermatol Clin. 2005;23(3):443–55. doi:https://doi.org/10.1016/j.det.2005.03.005.
- Nwaejike N, Srodon PD, Kyriakides C. Endovenous laser ablation for the treatment of recurrent varicose vein disease—a single-center experience. Int J Surg. 2010;8(4):299–301. doi:https://doi.org/10.1016/j.ijsu.2010.02.012.
- Galanopoulos G, Lambidis C. Minimally invasive treatment of varicose veins: Endovenous laser ablation (EVLA). Int J Surg. 2012;10(3):134–9. doi:https://doi.org/10.1016/j.ijsu.2012.02.013.
- Schwarz T, von Hodenberg E, Furtwängler C, Rastan A, Zeller T, Neumann FJ. Endovenous laser ablation of varicose veins with the 1470-nm diode laser. J Vasc Surg. 2010;51(6):1474–8. doi:https://doi.org/10.1016/j.jvs.2010.01.027.
- Nemoto H, Mo M, Ito T, Inoue Y, Obitsu Y, Kichikawa K, Yamaki T, Ogawa T, Venous thromboembolism complications after endovenous laser ablation for varicose veins and role of the duplex ultrasound scan. J Vasc Surg Venous Lymphat Disord. 2019;7(6):817–23. doi:https://doi.org/10.1016/j.jvsv.2019.06.014.
- Luo LH, Chen Z, Hu LN, Ma C, Xiao EH. Tumescence Anesthesia solution-assisted laser ablation treatment of lower limb varicose veins: the effect of temperature of the tumescence anesthesia solution on intraoperative and postoperative pain, clinical observations, and comprehensive nursing care. J Perianesth Nurs. 2019;34(2):368–75. doi:https://doi.org/10.1016/j.jopan.2018.06.091.
- Eissawy MG, Abd-ElGawad EA, El-Shereif MAE. Endovenous laser ablation of varicose veins. Egypt J Radiol Nucl Med. 2016;47(1):179–83. doi:https://doi.org/10.1016/j.ejrnm.2015.10.011.
- Tawfik AM, Sorour WA, El-Laboudy ME. Laser ablation versus mechanochemical ablation in the treatment of primary varicose veins: a randomized clinical trial. J Vasc Surg Venous Lymphat Disord. 2020;8(2):211–5. doi:https://doi.org/10.1016/j.jvsv.2019.10.025.
- van Groenendael L, van der Vliet JA, Flinkenflögel L, Roovers EA, van Sterkenburg SM, Reijnen MM. Treatment of recurrent varicose veins of the great saphenous vein by conventional surgery and endovenous laser ablation. J Vasc Surg. 2009;50(5):1106–13. doi:https://doi.org/10.1016/j.jvs.2009.06.057.
- Kumar A, Agarwal PN, Garg PK. Evaluation of subfascial endoscopic perforator vein surgery (SEPS) using harmonic scalpel in varicose veins: an observational study. Int J Surg. 2009;7(3):253–6. doi:https://doi.org/10.1016/j.ijsu.2009.04.005.
- Dwerryhouse S, Davies B, Harradine K, Earnshaw JJ. Stripping the long saphenous vein reduces the rate of reoperation for recurrent varicose veins: five-year results of a randomized trial. J Vasc Surg. 1999;29(4):589–92. doi:https://doi.org/10.1016/S0741-5214(99)70302-2.
- Bountouroglou DG, Azzam M, Kakkos SK, Pathmarajah M, Young P, Geroulakos G. Ultrasound-guided foam sclerotherapy combined with saphenofemoral ligation compared to surgical treatment of varicose veins: early results of a randomized controlled trial. Eur J Vasc Endovasc Surg. 2006;31(1):93–100. doi:https://doi.org/10.1016/j.ejvs.2005.08.024.
- Hummel T, Aryafar A, Mayböck N, Mumme A, Stücker M, Mühlberger D. Quality of life after varicose vein surgery in patients with high-ligation and stripping, external valvuloplasty, and saphenofemoral redo surgery. Ann Vasc Surg. 2021. doi:https://doi.org/10.1016/j.avsg.2020.12.057.
- Teruya TH, Ballard JL. New approaches for the treatment of varicose veins. Surg Clin North Am. 2004;84(5):1397–417. doi:https://doi.org/10.1016/j.suc.2004.04.008.
- Radak D, Djukic N, Neskovic M. Cyanoacrylate embolization: a novelty in the field of varicose veins surgery. Ann Vasc Surg. 2019;55:285–91. doi:https://doi.org/10.1016/j.avsg.2018.06.009.
- Pierik EGJM, Wittens CHA, van Urk H. Subfascial endoscopic ligation in the treatment of incompetent perforating veins. Eur J Vasc Endovasc Surg. 1995;9(1):38–41. doi:https://doi.org/10.1016/s1078-5884(05)80222-9.
- Jones R, Carek P. Management of varicose veins. Am Fam Physician. 2008;78(11):1289–94.
- Murray MT, Pizzorno J. 2010. The encyclopedia of healing foods. Simon and Schuster. New York City (NY): Atria Books.
- Duke JA. 2009. The green pharmacy guide to healing foods: Proven natural remedies to treat and prevent more than 80 common health concerns. Kutztown, (PA): Rodale.
- Goyal A, Sharma V, Upadhyay N, Gill S, Sihag M. Flax and flaxseed oil: an ancient medicine & modern functional food. J Food Sci Tech 2014;51(9):1633–53.
- Abebe W. Review of herbal medications with the potential to cause bleeding: dental implications, and risk prediction and prevention avenues. EPMA J. 2019;10(1):51–64. doi:https://doi.org/10.1007/s13167-018-0158-2.
- Rabe E, Guex J-J, Morrison N, Ramelet A-A, Schuller-Petrovic S, Scuderi A, Staelens I, Pannier F. Treatment of chronic venous disease with flavonoids: recommendations for treatment and further studies. Phlebology. 2013;28(6):308–19. doi:https://doi.org/10.1177/0268355512471929.
- Czaplińska M, Czepas J, Gwoździński K. Structure, antioxidative and anticancer properties of flavonoids. Postepy Biochem. 2012;58(3):235–44.
- Ganai AA, Khan AA, Malik ZA, Farooqi H. Genistein modulates the expression of NF-κB and MAPK (p-38 and ERK1/2), thereby attenuating d-Galactosamine induced fulminant hepatic failure in Wistar rats. Toxicol Appl Pharmacol. 2015;283(2):139–46. doi:https://doi.org/10.1016/j.taap.2015.01.012.
- Matsunaga N, Tsuruma K, Shimazawa M, Yokota S, Hara H. Inhibitory actions of bilberry anthocyanidins on angiogenesis. Phytother Res. 2010;24(S1):S42–S47. doi:https://doi.org/10.1002/ptr.2895.
- Bakhtiari M, Panahi Y, Ameli J, Darvishi B. Protective effects of flavonoids against Alzheimer’s disease-related neural dysfunctions. Biomed Pharmacother. 2017;93:218–29. doi:https://doi.org/10.1016/j.biopha.2017.06.010.
- Katsenis K. Micronized purified flavonoid fraction (MPFF)*: a review of its pharmacological effects, therapeutic efficacy and benefits in the management of chronic venous insufficiency. Curr Vasc Pharmacol. 2005;3(1):1–9. doi:https://doi.org/10.2174/1570161052773870.
- Maria das Graças C, Cyrino FZ, de Carvalho JJ, Blanc-Guillemaud V, Bouskela E. Protective effects of micronized purified flavonoid fraction (MPFF) on a novel experimental model of chronic venous hypertension. Eur J Vasc Endovasc Surg. 2018;55(5):694–702. doi:https://doi.org/10.1016/j.ejvs.2018.02.009.
- Rohdewald P. A review of the French maritime pine bark extract (Pycnogenol), a herbal medication with a diverse clinical pharmacology. Int J Clin Pharmacol Ther. 2002;40(4):158–68. doi:https://doi.org/10.5414/cpp40158.
- Gulati OP. Pycnogenol® in chronic venous insufficiency and related venous disorders. Phytother Res. 2014;28(3):348–62. doi:https://doi.org/10.1002/ptr.5019.
- Gohil KJ, Patel JA, Gajjar AK. Pharmacological review on Centella asiatica: a potential herbal cure-all. Indian J Pharm Sci. 2010;72(5):546–56. doi:https://doi.org/10.4103/0250-474X.78519.
- Gullón B, Lú-Chau TA, Moreira MT, Lema JM, Eibes G. Rutin: a review on extraction, identification and purification methods, biological activities and approaches to enhance its bioavailability. Trends Food Sci Technol. 2017;67:220–35. doi:https://doi.org/10.1016/j.tifs.2017.07.008.
- van Beek TA. Chemical analysis of Ginkgo biloba leaves and extracts. J Chromatogr A. 2002;967(1):21–55. doi:https://doi.org/10.1016/S0021-9673(02)00172-3.
- Strømgaard K, Nakanishi K. Chemistry and biology of terpene trilactones from Ginkgo biloba. Angew Chem Int Ed Engl. 2004;43(13):1640–58. doi:https://doi.org/10.1002/anie.200300601.
- Ding H, Zhang Z, Cao S, Xu Y, Yu J. Transformation of multi-component Ginkgolide into Ginkgolide B by Coprinus comatus. BMC Biotechnol. 2015;15(1):1–11. doi:https://doi.org/10.1186/s12896-015-0133-0.
- Guha A. 2005. Therapeutic use of Ginkgo biloba.
- Lim H, Son KH, Chang HW, Kang SS, Kim HP. Effects of anti-inflammatory biflavonoid, ginkgetin, on chronic skin inflammation. Biol Pharm Bull. 2006;29(5):1046–9. doi:https://doi.org/10.1248/bpb.29.1046.
- Garg N, Jain A. Ayurvedic perspective of varicose veins. World J Pharm Res. 2017;6(3)
- Mor D, Dande P. Varicose veins: an overview of current and herbal treatments. Int J Pharm Sci Res. 2017;8(5):1959.
- Hollingsworth SJ, Tang CB, Barker SGE. An in vitro model for the molecular investigation of varicose veins: use of cultured explants of the human long saphenous vein. Phlebology. 2001;16(2):53–9. doi:https://doi.org/10.1177/026835550101600202.
- Boisnic S, Branchet MC, Gouhier‐Kodas C, Verriere F, Jabbour V. Anti‐inflammatory and antiradical effects of a 2% diosmin cream in a human skin organ culture as a model. J Cosmet Dermatol. 2018;17(5):848–54. doi:https://doi.org/10.1111/jocd.12778.